Healthcare - Page 1 | TalkMarkets
All Posts > Content under Healthcare
1 to 16 of 4723 Posts
1 2 3 ... 296
Catalyst Biosciences - Chart Of The Day
Article By: Jim Van Meerten
Thursday, January 18, 2018 8:30 PM EST
Revenue for the company previous known as Targacept is expected to grow 103.00% this year and another 125.90% next year.
In this article: CBIO
Read
M&A Waves Pushing Biotech ETFs Higher
Article By: Sweta Killa
Thursday, January 18, 2018 2:16 PM EST
The biotech corner of the broad healthcare sector is in the spotlight to start the New Year, as the new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of mergers and acquisitions.
In this article: FBT, PBE, BBC, CNCR Also: CELG, JUNO
Read
Citi Downgrades Juno To Neutral, Says Potential Takeover Priced In
Article By: The Fly
Thursday, January 18, 2018 7:24 AM EST
Citi analyst Robyn Karnauskas last night downgraded Juno Therapeutics to Neutral from Buy while raising her price target for the shares to $81 from $59.
In this article: JUNO Also: CELG
Read
Three Stocks That Could Still Leap After Earnings
Article By: TipRanks
Wednesday, January 17, 2018 2:22 PM EST
Earnings season has now kicked off, and word on the Street is that it’s going to be very good.
In this article: ABT, SBUX, FB
Read
Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal
Article By: The Fly
Wednesday, January 17, 2018 12:59 PM EST
Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene.
In this article: JUNO Also: CELG, GILD, BLUE, CLLS, BLCM
Read
4 Great Healthcare Stocks To Buy Ahead Of Q4 Earnings
Article By: Swarup Gupta
Wednesday, January 17, 2018 10:28 AM EST
The healthcare sector exited 2017 quite creditably. Such gains are likely to continue with the Health Care Select Sector SPDR (XLV) up 23% over the last one year, a shade higher than the S&P 500’s increase of 22.1%.
In this article: HUM, CNC, BIVV, ANTM
Read
HTG Molecular Diagnostics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, January 16, 2018 10:31 PM EST
HTG Molecular Diagnostics, Inc. today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.
In this article: HTGM
Read
UnitedHealth (UNH) Beats On Q4 Earnings, Revises 2018 View
Article By: Zacks Investment Research
Tuesday, January 16, 2018 1:24 PM EST
UnitedHealth Group Inc. came up with earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.50. Earnings also rose 22.7% year over year.
In this article: UNH Also: CNC, HUM, ANTM
Read
AveXis Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, January 16, 2018 11:28 AM EST
AveXis, Inc. today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an underwritten public offering.
In this article: AVXS
Read
Merck & Co. Inc Shares Fly High On Positive Lung Cancer Trial
Article By: TickerTV
Tuesday, January 16, 2018 10:57 AM EST
On Tuesday before the market opened, shares of Merck & Co were gapping up on news of positive results from their lung cancer trial.
In this article: MRK
Read
Large Cap Biopharmaceuticals: Performance And Metric Update
Article By: Rod Raynovich
Tuesday, January 16, 2018 7:52 AM EST
An update of Large Cap Biopharmaceuticals Performance over the past 12 months.
In this article: IBB, ABBV, AMGN, BIIB, RGEN, XBI
Read
Eli Lilly Downgraded To Neutral From Buy At Goldman Sachs
Article By: The Fly
Tuesday, January 16, 2018 5:46 AM EST
Goldman Sachs analyst Jami Rubin downgraded Eli Lilly to Neutral and cut her price target for the shares to $95 from $98.
In this article: LLY Also: NVO
Read
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
This Controversial Industry Is Here To Stay
Article By: Chad Shoop
Monday, January 15, 2018 2:30 PM EST
The way this Marijuana industry as a whole has reacted to the recent news has convinced me it is here to stay, and if you don’t have exposure to it yet — now is the time.
In this article: CBIS, TWMJF
Read
3 Pharma And Biotech Stocks To Watch Out For In 2018
Article By: Arpita Dutt
Monday, January 15, 2018 10:33 AM EST
2017 turned out to be a pretty good year for pharma and biotech stocks with the Nasdaq Biotechnology index and the NYSE Arca Pharmaceutical index gaining 18.7% and 11.8%, respectively.
In this article: EIGR, XOMA, ALKS Also: NVS, BIIB
Read
Ask Slim Market Week - Friday, Jan. 12
Video By: Steve Miller
Friday, January 12, 2018 6:53 PM EST
This week saw buyers coming into the market non-stop in all sectors including microcaps and small caps. Does this mean the market is coming to the end of the nine year bull rally?
In this video: BA, DAL, DDS, GME, KBH, NE, TGT, UAL, TEVA, FB, GPRO, UAA, SLV
Watch
1 to 16 of 4723 Posts
1 2 3 ... 296